EUVIMEDEUVIMED entdecken
Fallbericht

Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: A case series and discussion

Madilyn Harris, Jacqueline Bishop, William J Olney, Dina Ali, Alexis Nickols, Sara E Parli

American Journal of Health-System Pharmacy · 2025

DOI: 10.1093/ajhp/zxaf099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Madilyn Harris und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA. Hauptthemen laut MEDLINE: Hematinics, Anemia, Wounds and Injuries, Erythropoietin. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Individuals may abstain from blood products due to religious or cultural beliefs. For trauma victims, blood loss is associated with anemia, decreasing oxygen delivery, and alternative treatment methods to blood transfusion are warranted in this population. Literature has investigated the use of epoetin alfa, an albumin-containing erythropoiesis-stimulating agent (ESA), to treat anemia for this indication; however, this may be problematic as albumin is a blood-derived product. Darbepoetin alfa is an albumin-free ESA alternative. This case series describes the use of darbepoetin alfa on anemia and outcomes in patients who abstain from blood products. Summary Trauma and acute care surgery patients are at risk for development of anemia related to traumatic injury as well as acute blood loss. Blood product transfusion is a common therapeutic intervention; however, patients may abstain from blood product administration. The 9 patients described herein with anemia (hemoglobin concentration of <7 g/dL or hematocrit level of <21%) during a hospital stay abstained from blood products and received darbepoetin alfa. Initial hemoglobin levels ranged from 4.1 to 10.1 g/dL, and patients received darbepoetin from 1 day to up to 17 consecutive days during their hospital stay. One patient experienced a type II non–ST elevation myocardial infarction.

Conclusion

The use of darbepoetin alfa appeared to be a therapeutic option to treat anemia in trauma and acute care surgery patients who abstain from blood products. Future studies are needed to compare epoetin alfa and darbepoetin alfa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HematinicsAnemiaWounds and InjuriesErythropoietinHumansDarbepoetin alfaMaleFemaleMiddle AgedAgedAdultBlood TransfusionAcute Care Surgery

Stichwörter der Autor:innen

anemiadarbepoetin alfaepoetin alfaerythropoiesis-stimulating agentsurgerywounds and injuries

Substanzen

Darbepoetin alfaHematinicsErythropoietin

Autor:innen und Institutionen

  • Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY, USA.
  • Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY.
  • Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA.
  • Department of Acute Care Surgery, Trauma, and Surgical Critical Care, University of Kentucky HealthCare, Lexington, KY, USA.

Zitieren

APA

Harris, M., Bishop, J., Olney, W. J., Ali, D., Nickols, A., & Parli, S. E. (2025). Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: A case series and discussion. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxaf099

Vancouver

Harris M, Bishop J, Olney WJ, Ali D, Nickols A, Parli SE. Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: A case series and discussion. American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxaf099

BibTeX
@article{Harris2025,
  author = {Harris, Madilyn and Bishop, Jacqueline and Olney, William J and Ali, Dina and Nickols, Alexis and Parli, Sara E},
  title = {Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: A case series and discussion},
  journal = {American Journal of Health-System Pharmacy},
  year = {2025},
  doi = {10.1093/ajhp/zxaf099}
}
Kostenlos starten →